Fani Kalala

483 citations
28 papers · 355 indexed · h-index 9
Topics
SARS-CoV-2 and COVID-19 Research (4 papers)Immunodeficiency and Autoimmune Disorders (4 papers)Eosinophilic Disorders and Syndromes (4 papers)
Partner nations
GreeceAustriaGermany

In The Last Decade

Fani Kalala

26 papers receiving 347 citations

Peers

Fani Kalala
Comparison fields: 5 of 72
  • Immunology 182
  • Oncology 91
  • Molecular Biology 77
  • Epidemiology 50
  • Cancer Research 47
Replace Qiangguo Gao with:
Qiangguo Gao China
Siobhán Smith Ireland
Tim J. Vyse United Kingdom
Elham Roshandel Iran
Gregory Schneiter Switzerland
Philip Tombleson United Kingdom
Hila Shaim United States
Ido Sloma United States
Georgia Afonso France
Elisa Artusio Italy
Fani Kalala relative to Qiangguo Gao China Qiangguo Gao's profile →
Citations per field
00.5×
Qiangguo Gao · 1×
Citations per year

Countries citing papers authored by Fani Kalala

Since Specialization
Citations

This map shows the geographic impact of Fani Kalala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fani Kalala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fani Kalala more than expected).

Fields of papers citing papers by Fani Kalala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fani Kalala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fani Kalala. The network helps show where Fani Kalala may publish in the future.

Co-authorship network of co-authors of Fani Kalala

This figure shows the co-authorship network connecting the top 25 collaborators of Fani Kalala. A scholar is included among the top collaborators of Fani Kalala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fani Kalala. Fani Kalala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 0
5 2
6 2
7 4
8 33
9 4
10 4
11 2
12 5
13 14
14 11
15 19
16 14
17 173
18 11
19 3
20 5

About Fani Kalala

Fani Kalala is a scholar working on Immunology, Genetics and Infectious Diseases, having authored 28 papers that have together received 355 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Immunology (182 citations), Genetics (36 citations) and Oncology (91 citations). Fani Kalala has collaborated with scholars based in Greece, Austria and Germany. Frequent co-authors include Matthaios Speletas, Anastasios E. Germenis, Gedeon Loules, Konstantinos I. Gourgoulianis, Vaios Karanikas, Theodora Kerenidi, Μαρία Ζαμανάκου, Chrysoula Marogianni, Georgia Xiromerisiou and Stamatia Papoutsopoulou. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Experimental Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026